Potential of natural products in combination with arsenic trioxide: Investigating cardioprotective effects and mechanisms - 29/04/23
Abstract |
Over the past few decades, clinical trials conducted worldwide have demonstrated the efficacy of arsenic trioxide (ATO) in the treatment of relapsed acute promyelocytic leukemia (APL). Currently, ATO has become the frontline treatments for patients with APL. However, its therapeutic applicability is severely constrained by ATO-induced cardiac side effects. Any cardioprotective agents that can ameliorate the cardiac side effects and allow exploiting the full therapeutic potential of ATO, undoubtedly gain significant attention. The knowledge and use of natural products for evidence-based therapy have grown rapidly in recent years. Here we discussed the potential mechanism of ATO-induced cardiac side effects and reviewed the studies on cardiac side effects as well as the research history of ATO in the treatment of APL. Then, We summarized the protective effects and underlying mechanisms of natural products in the treatment of ATO-induced cardiac side effects. Based on the efficacy and safety of the natural product, it has a promising future in the development of cardioprotective agents against ATO-induced cardiac side effects.
Le texte complet de cet article est disponible en PDF.Abbreviations : APL, ATO, ATRA, ATF6, AKT, AMPK, AP-1, Bax, CAT, CHOP, CR, DHA, ECG, EPA, ER, ERK, ETC, GSH-Px, GPX4, GRP78, HDL, HO-1, Hsp, HUVEC, IGF1, IFN-γ, IL, IRE1, JNK, KEAP1, LDL, LQTs, MAPK, MCP-1, MDA, MI, MRP, mPTP, mTORC, NADPH, NF-κB, NFATc, Nrf2, PGC-1, PERK, PI3K, PML, proto-oncogene, QTc, RARA, ROS, SIRT, Sal A, Sal B, SERCA, SPF, SOD, TGF-1, TNF-α, TLR4
Keywords : Natural products, Phytochemicals, Cardiac protection, Arsenic trioxide, Cardiac side effects, Acute promyelocytic leukemia
Plan
Vol 162
Article 114464- juin 2023 Retour au numéro
Article précédent
- ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies
- Shu Yang, Xiaomin Wang, Xintong Zhou, Lin Hou, Jibiao Wu, Wenfeng Zhang, Huayao Li, Chundi Gao, Changgang Sun
- A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes
- Jing Song, Guan-Nan He, Long Dai
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?